International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma
Go back to International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma| (NASDAQ: BBIO) | Delayed: 72.65 +0.21 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.44 | 52 Week High | $ | |||
| Open | $72.55 | 52 Week Low | $ | |||
| Day High | $73.32 | P/E | N/A | |||
| Day Low | $72.21 | EPS | $ | |||
| Volume | 192,821 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 215.93 -1.22 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $217.15 | 52 Week High | $333.65 | |||
| Open | $221.00 | 52 Week Low | $223.02 | |||
| Day High | $222.25 | P/E | 27.65 | |||
| Day Low | $215.56 | EPS | $7.81 | |||
| Volume | 43,946 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1135.05 +19.35 (1.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1115.70 | 52 Week High | $88.16 | |||
| Open | $1142.20 | 52 Week Low | $67.88 | |||
| Day High | $1153.95 | P/E | 262.74 | |||
| Day Low | $1130.50 | EPS | $4.32 | |||
| Volume | 410,278 | |||||
| (NASDAQ: NTHI) | Delayed: 3.82 +0.14 (3.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.68 | 52 Week High | $ | |||
| Open | $3.82 | 52 Week Low | $ | |||
| Day High | $4.00 | P/E | N/A | |||
| Day Low | $3.74 | EPS | $ | |||
| Volume | 36,535 | |||||

